Professional Documents
Culture Documents
net/publication/344830895
CITATION READS
1 436
3 authors:
Mudasir Firdosi
Kent and Medway NHS and Social Care Partnership Trust
35 PUBLICATIONS 197 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
The Glutamate Hypothesis of Mood Disorders: Neuroplasticity Processes, Clinical Features, Treatment Perspectives View project
All content following this page was uploaded by Mudasir Firdosi on 07 December 2020.
DOI: 10.1192/bja.2020.71
SUMMARY
Neuroleptic malignant syndrome (NMS) is a rare and potentially fatal adverse reaction to drugs. In psychiatric
practice, it is mainly associated with antipsychotics. The classic presentation is that of hyperpyrexia, muscle rigidity,
mental state changes and autonomic instability. Subtle forms are difficult to recognise owing to symptom overlap
with other conditions. This article discusses the clinical presentation of the syndrome, its differential diagnosis and
use of supportive care, medication and electroconvulsive therapy in its treatment. It also explores prevention of NMS
and reinstatement of treatment after an episode. It is stressed that all but the mildest forms of NMS should be
considered a medical emergency that is properly managed in an acute hospital.